• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄胎:早期诊断、临床管理及转诊中心的作用

Molar Pregnancy: Early Diagnosis, Clinical Management, and the Role of Referral Centers.

作者信息

Braga Antônio, Coutinho Lohayne, Chagas Marcela, Soares Juliana Pereira, Callado Gustavo Yano, Alevato Raphael, Lozoya Consuelo, Sun Sue Yazaki, Araujo Júnior Edward, Rezende-Filho Jorge

机构信息

Department of Gynecology and Obstetrics, School of Medicine, Federal University of Rio de Janeiro (UFRJ), Rua das Laranjeiras, No. 180, Laranjeiras, Rio de Janeiro 22240-003, RJ, Brazil.

Department of Maternal and Child Health, Postgraduate Program in Medical Sciences, School of Medicine, Fluminense Federal University (UFF), Niterói 24070-090, RJ, Brazil.

出版信息

Diagnostics (Basel). 2025 Aug 4;15(15):1953. doi: 10.3390/diagnostics15151953.

DOI:10.3390/diagnostics15151953
PMID:40804917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12346673/
Abstract

Molar pregnancy (MP) is a gestational disorder resulting from abnormal fertilization, leading to atypical trophoblastic proliferation and the formation of a complete or partial hydatidiform mole. This condition represents the most common form of gestational trophoblastic disease (GTD) and carries a significant risk of progression to gestational trophoblastic neoplasia (GTN). Although rare in high-income countries, MP remains up to ten times more prevalent in low-income and developing countries, contributing to preventable maternal morbidity and mortality. This narrative review provides an updated, practical overview of the clinical presentation, diagnosis, treatment, and follow-up of MP. A key focus is the challenge of early diagnosis, particularly given the increasing frequency of first-trimester detection, where classical histopathological criteria may be subtle, leading to diagnostic errors. The review innovates by integrating advanced diagnostic methods-combining histopathology, immunohistochemistry using p57Kip2, Ki-67, and p53 markers, along with cytogenetic analysis-to improve diagnostic accuracy in early gestation. The central role of referral centers is also emphasized, not only in facilitating timely treatment and access to chemotherapy, but also in implementing standardized post-molar follow-up protocols that reduce progression to GTN and maternal mortality. By focusing on both advanced diagnostic strategies and the organization of care through referral centers, this review offers a comprehensive, practice-oriented perspective to optimize patient outcomes in GTD and address persistent care gaps in high-burden regions.

摘要

葡萄胎(MP)是一种由异常受精导致的妊娠疾病,会引起非典型滋养层细胞增殖,并形成完全性或部分性葡萄胎。这种情况是妊娠滋养细胞疾病(GTD)最常见的形式,具有发展为妊娠滋养细胞肿瘤(GTN)的重大风险。尽管在高收入国家中较为罕见,但葡萄胎在低收入和发展中国家的患病率仍然高出多达十倍,这导致了可预防的孕产妇发病和死亡。本叙述性综述提供了关于葡萄胎临床表现、诊断、治疗及随访的最新实用概述。一个关键重点是早期诊断的挑战,特别是考虑到孕早期检测频率的增加,此时经典组织病理学标准可能不明显,从而导致诊断错误。该综述通过整合先进的诊断方法进行创新,将组织病理学、使用p57Kip2、Ki-67和p53标记物的免疫组织化学以及细胞遗传学分析相结合,以提高早孕诊断的准确性。还强调了转诊中心的核心作用,不仅在于促进及时治疗和获得化疗,还在于实施标准化的葡萄胎后随访方案,以减少发展为GTN和孕产妇死亡的情况。通过关注先进的诊断策略以及通过转诊中心进行的护理组织,本综述提供了一个全面的、以实践为导向的视角,以优化GTD患者的治疗结果,并解决高负担地区持续存在的护理差距。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/27fd52a206b4/diagnostics-15-01953-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/de05ceee6b0c/diagnostics-15-01953-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/d223067de458/diagnostics-15-01953-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/ddcfe043fc82/diagnostics-15-01953-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/ea083396ea7d/diagnostics-15-01953-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/5db756ddb9cb/diagnostics-15-01953-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/f9aa11e273af/diagnostics-15-01953-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/813977377b80/diagnostics-15-01953-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/2db422999dee/diagnostics-15-01953-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/3355eaa655a1/diagnostics-15-01953-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/27fd52a206b4/diagnostics-15-01953-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/de05ceee6b0c/diagnostics-15-01953-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/d223067de458/diagnostics-15-01953-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/ddcfe043fc82/diagnostics-15-01953-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/ea083396ea7d/diagnostics-15-01953-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/5db756ddb9cb/diagnostics-15-01953-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/f9aa11e273af/diagnostics-15-01953-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/813977377b80/diagnostics-15-01953-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/2db422999dee/diagnostics-15-01953-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/3355eaa655a1/diagnostics-15-01953-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/886d/12346673/27fd52a206b4/diagnostics-15-01953-g010.jpg

相似文献

1
Molar Pregnancy: Early Diagnosis, Clinical Management, and the Role of Referral Centers.葡萄胎:早期诊断、临床管理及转诊中心的作用
Diagnostics (Basel). 2025 Aug 4;15(15):1953. doi: 10.3390/diagnostics15151953.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.预防性化疗用于葡萄胎以预防妊娠滋养细胞肿瘤。
Cochrane Database Syst Rev. 2017 Sep 11;9(9):CD007289. doi: 10.1002/14651858.CD007289.pub3.
4
Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.预防性化疗用于葡萄胎以预防妊娠滋养细胞肿瘤。
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD007289. doi: 10.1002/14651858.CD007289.pub2.
5
Immunohistochemical Staining: Prognostic Marker of Malignant Transformation of Hydatidiform Mole (HM).免疫组织化学染色:葡萄胎(HM)恶性转化的预后标志物。
J Obstet Gynaecol India. 2025 Apr;75(Suppl 1):365-370. doi: 10.1007/s13224-024-02002-7. Epub 2024 Jul 23.
6
Ophthalmia Neonatorum新生儿眼炎
7
First-line chemotherapy in low-risk gestational trophoblastic neoplasia.低危妊娠滋养细胞肿瘤的一线化疗
Cochrane Database Syst Rev. 2016 Jun 9;2016(6):CD007102. doi: 10.1002/14651858.CD007102.pub4.
8
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.改善消费者安全有效用药的干预措施:系统评价概述
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3.
9
Nocardia Keratitis诺卡菌性角膜炎
10
Routine ultrasound for fetal assessment before 24 weeks' gestation.24 周妊娠前常规胎儿评估超声检查。
Cochrane Database Syst Rev. 2021 Aug 26;8(8):CD014698. doi: 10.1002/14651858.CD014698.

本文引用的文献

1
Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD)-European Society of Gynaecologic Oncology (ESGO)-Gynecologic Cancer InterGroup (GCIG)-International Society for the Study of Trophoblastic Diseases (ISSTD).妊娠滋养细胞疾病治疗实用指南:欧洲滋养细胞疾病治疗组织(EOTTD)-欧洲妇科肿瘤学会(ESGO)-妇科癌症国际协作组(GCIG)-国际滋养细胞疾病研究学会(ISSTD)合作制定
J Clin Oncol. 2025 Jun 20;43(18):2119-2128. doi: 10.1200/JCO-24-02326. Epub 2025 May 13.
2
Pathology of Gestational Trophoblastic Disease (GTD).妊娠滋养细胞疾病(GTD)的病理学。
Hematol Oncol Clin North Am. 2024 Dec;38(6):1191-1217. doi: 10.1016/j.hoc.2024.08.017. Epub 2024 Sep 24.
3
Epidemiology of Gestational Trophoblastic Disease.妊娠滋养细胞疾病的流行病学。
Hematol Oncol Clin North Am. 2024 Dec;38(6):1173-1190. doi: 10.1016/j.hoc.2024.07.003. Epub 2024 Sep 5.
4
Contraceptive use following gestational trophoblastic disease: A systematic review.妊娠滋养细胞疾病后避孕方法的使用:系统评价。
Contraception. 2024 Sep;137:110488. doi: 10.1016/j.contraception.2024.110488. Epub 2024 May 17.
5
Gestational trophoblastic neoplasia: does centralization of care impact clinical management?妊娠滋养细胞肿瘤:集中化管理是否会影响临床治疗?
Int J Gynecol Cancer. 2023 Nov 6;33(11):1724-1732. doi: 10.1136/ijgc-2023-004526.
6
The impact of the distance traveled between residence and gestational trophoblastic neoplasia reference center and clinical outcomes in Brazilian women.居住地点与妊娠滋养细胞肿瘤参考中心之间的距离对巴西女性临床结局的影响。
Gynecol Oncol. 2023 Sep;176:130-138. doi: 10.1016/j.ygyno.2023.07.012. Epub 2023 Jul 29.
7
When to Consult a Geneticist Specialising in Gestational Trophoblastic Disease.何时咨询专门从事滋养细胞疾病的遗传学家。
Gynecol Obstet Invest. 2024;89(3):198-213. doi: 10.1159/000531218. Epub 2023 May 26.
8
Treatments and outcomes in high-risk gestational trophoblastic neoplasia: A systematic review and meta-analysis.高危型妊娠滋养细胞肿瘤的治疗和结局:系统评价和荟萃分析。
BJOG. 2023 Apr;130(5):443-453. doi: 10.1111/1471-0528.17374. Epub 2023 Jan 25.
9
The diagnostic value and accuracy of ultrasound in diagnosing hydatidiform mole: A systematic review and meta-analysis of the literature.超声在诊断葡萄胎中的诊断价值和准确性:文献的系统评价和荟萃分析。
Radiography (Lond). 2022 Nov;28(4):897-905. doi: 10.1016/j.radi.2022.06.005. Epub 2022 Jul 1.
10
Changes in diagnostic sensitivity, incidence and presentation of complete and partial hydatidiform mole over the years.多年来完全性和部分性葡萄胎的诊断灵敏度、发生率和表现的变化。
Eur J Obstet Gynecol Reprod Biol. 2022 Jul;274:136-141. doi: 10.1016/j.ejogrb.2022.05.026. Epub 2022 May 25.